期刊
VACCINE
卷 25, 期 -, 页码 B89-B96出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2007.04.091
关键词
immunotherapy; vaccine; clinical protocols; prostate cancer; prostate-specific antigen; cancer vaccine; combination therapy; hormone therapy; chemotherapy; radiation therapy; Anti-CTLA-4
资金
- Intramural NIH HHS [Z99 CA999999] Funding Source: Medline
Novel strategies are emerging from preclinical and clinical investigations for combining vaccines with conventional and experimental anticancer therapies. Several lines of research show that combining either radiation or certain chemotherapeutic agents with vaccine can alter the phenotype of tumor cells, rendering them more susceptible to T cell-mediated killing. Furthermore, there is emerging data suggesting that an immune response elicited by vaccine may augment the antitumor effectiveness of subsequent therapies. This article reviews and discusses therapeutic cancer strategies that employ vaccines sequentially or in combination with conventional cytotoxic therapies such as local radiation, chemotherapy, and hormone therapy, or immunopotentiating therapies such as anti-CTLA-4 monoclonal antibodies. Preliminary results of clinical studies using these combination strategies have demonstrated a postvaccination antigen cascade, prolonged time to disease progression, and preliminary evidence of improved overall survival. Large randomized studies are currently underway to further investigate these findings.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据